In the near future, we will focus on figuring out which exact cytokine is playing a key role in the ASPP2 knockdown event and hopefully develop novel strategies for the prevention and treatment of proliferative vitreoretinopathy. The gene discussed is TP53BP2; the disease is proliferative vitreoretinopathy.